
æ°ããå»çæè¡ã§å±éºã«ããããããèªç±ããã©ã€ãã·ãŒ
2020幎10æ6æ¥
By admin
å èšäºã¯ãã¡ãã
ãã€ã¯ããããããããã¯ãããžãŒãåã蟌ã¿åãã€ãªã»ã³ãµãŒïŒäººäœå ãããïŒã話é¡ã«ãªã£ãŠããŸãã
以äžã®èšäºã¯ãäœå®¶ã®ãã ã»ãã³ã°ãChildren's Health DefenseïŒCHDïŒãŠã§ããµã€ãã«æ²èŒãããã®ã§ãã
ãç±³è»å µå£«ã¯ãå¥åº·ç¶æ ã®æé©åãšçŸç çºçã®æ©æçºèŠã远æ±ãããããã¯ãããžãŒè©Šéšã®æåã®è¢«éšè ã«ãªãã§ãããããããã¥ãŒã¶ïŒçäœå·¥åŠã»ã³ãµãŒã®éçºãå¯èœã«ããããšãæ±ããŠãããšäž»åŒµïŒã¯ãç±³åœåœé²ç·çãšåœé²é«çç ç©¶èšç»å±ïŒDARPAïŒãšçäœçµ±ååã»ã³ãµãŒã®ç ç©¶å¥çŽãçµãã§ããã2021幎åãã®ç±³åœé£åå»è¬åå±ã®èªå¯åŸ ã¡ã§ãã
"å¥åº·ãã¯ãããžãŒÂ "ã¯èªç±ãšãã©ã€ãã·ãŒãæãªãã
"ãããã¥ãŒã¶Â "ã®ããã¢ãŒã·ã§ã³ãããªã§ã¯ãçäœçµ±åã»ã³ãµãŒã«ãã£ãŠãé žçŽ æ¿åºŠãå¿ææ°ãªã©ã®ãã€ãªããŒã«ãŒããªã¢ã«ã¿ã€ã ã§ç£èŠããã ãã§ãªããGPSã䜿ã£ãŠå µå£«ããªã¢ãŒãã³ã³ãã¥ãŒã¿ã§è¿œè·¡ããããšãã§ããããšã玹ä»ããŠããŸãããã®ãã€ãªãã¯ãããžãŒã¯ãæŠå Žã«ããå µå£«ã®åœãæãå¯èœæ§ãããããã«æãããŠããããGPSã§å人ã远跡ãããšããæå³ã¯ãäžè¬ã®äººã ã«ãããç£èŠåœå®¶ãžã®æãããäžæ©ãšãªããã®ã§ãããããã«ãç æ°ã®æ®µéã«ãã人ã ã远跡ããããšã¯ããããªãæ¿åºã®æã«ããããå»çå°å¶æ¿æ²»ãããããã ãã§ãããProfusaã€ã³ãã«ãšã³ã¶ç ç©¶ã§ã¯ãæ£è ã«ãŠã§ã¢ã©ãã«çã®ãªãŒããŒã24æéè£ çããŠããããç¶ç¶çã«ãã€ãªããŒã«ãŒæ å ±ãããŒã¿ããŒã¹ã«åéããææã®4段éãæ€åºããããšãç®çãšããŠããŸããå¥åº·æãæææãç¡çç¶æãå埩æã®4段éã§ãããããã®ä¿¡é Œæ§ã®äœãæ€åºæ®µéã¯ãæç¶äžå¯èœãªCOVID-19ã®åœå®¶ã¬ãã«ã®å€§è¡åãããã¯ããŠã³ã§çµéšããããã«ãå人ã®ç€ŸäŒåå ã®ã¬ãã«ã®éãã®åºæºãšãªãå¯èœæ§ããããŸãã
"é転 "ã§ããã®ãïŒæåŠããããšãã§ããã®ãïŒ
"ãã®ãããã¥ãŒã¶ã®ãããã¯ãããžãŒã¯3ã€ã®èŠçŽ ãæã£ãŠããŸãã
ãã€ããã²ã«ãšåŒã°ããæ¿å
¥åã»ã³ãµãŒãç®è衚é¢ã®çºå
åèå
ã»ã³ãµãŒãªãŒããŒããªã³ã©ã€ã³ããŒã¿ããŒã¹ã«éä¿¡ããé»åãœãããŠã§ã¢éšåã§ããã
SARS-CoV-2ã¯ã¯ãã³ã«ã¯ãã®æè¡ãçµã¿èŸŒãŸããäºå®ã§ããããã®æè¡ãåãé€ããããšããããã©ã®ãããªæ¹æ³ãªã®ãã«ã€ããŠã®æ
å ±ã¯ãªããã身äœãšäžäœåããå°ããªãã€ãªã»ã³ãµãŒãã¯ãçæ¶¯ããããåãçµã¿ãæå³ããã®ãããããªãã
"DARPA "ã®ãããã¯ãããžãŒç ç©¶ã¯éåžžã«è°è«ãåŒãã§ããã人工ç¥èœãåããæèŠã®é«ãŸãã10åã®èŠåã䞊å€ãã匷ããªã©ã人éã«åŒ·åãããèœåãäžãããã¹ãŒããŒå
µå£«ããäœãããšãç®æããŠããã
DARPAã®å£°æã«ãããšããç¥çµå·¥åŠã·ã¹ãã ãã¶ã€ã³ããšããŠç¥ããããã®ããã°ã©ã ã¯ããè³ãšé»åæ©åšã®éã«é«åºŠãªä¿¡å·åè§£èœãšããŒã¿è»¢é垯åå¹
ãæäŸã§ããåã蟌ã¿åç¥çµã€ã³ã¿ãŒãã§ãŒã¹ã®éçºãç®æãããšã®ããšã ããã®ãããªãè¶
èœåãããã®å¯äœçšã¯æ°žä¹
çãªãã®ãªã®ãããããšãçåœãçµ¶ã€ãã®ãªã®ãïŒDARPAã®ããã°ã©ã ã®ãŠã§ãããŒãžã«ã¯ããæã广çãªæå
端ã®ç¥çµã€ã³ã¿ãŒãã§ãŒã¹ã¯ãè³ã«é»æ¥µãåã蟌ãæè¡ãå¿
èŠã§ããããšèšãããŠããã
"ä»»åäžäžå¯æ¬ ããããã¯æŠåä¿è·ã®ããã«ãå µå£«ã«ãããã¯ãããžãŒã®åã蟌ã¿ãèŠæ±ããããšã¯å«ççã«å¯èœãªã®ãïŒè»äººã¯ãã¯ã¯ãã³åœä»€ãææ®ç³»çµ±ããã®å¥åº·åœä»€ã«çµã¿èŸŒãŸãããããã¯ãããžãŒãæåŠã§ããã®ãïŒã€ã³ãã©ãŒã ãã³ã³ã»ã³ããšåŒ·å¶ãããªãåæã¯ãå»çå«çã®åºç€ã§ããã
"ã¯ã¯ãã³"ããããã¯ãããžãŒã®äžççæ®åã®ããã®ããã€ã®æšéЬïŒ
"MITã®å µå£«ãããã¯ãããžãŒç ç©¶æãšç±³éžè»äŒæç ç ç©¶æã¯ããã©ãªã¢ãçµæ žãHIVããšãã©ã«å¯Ÿããè»çšã®æ°ããã¯ã¯ãã³ã§ãããã¯ãããžãŒã«åºã¥ãã¢ãžã¥ãã³ãã®äœ¿çšãç ç©¶ããŠããã
ãã®ææžã«ãããšãããããžã§ã¯ã1.6ã§ã¯ãã¯ã¯ãã³æ¥çš®ãšæ²»çã®å Žé¢ã§å®å šãã€å¹ççã«å ç«åå¿ãä¿é²ãã2ã€ã®ãã©ãããã©ãŒã æè¡ã®éçºãææ¡ããŠããããšãããŸãããªã³ãç¯ãæšçãšããäž¡èŠªåªæ§ã¢ãžã¥ãã³ããšãå ç«æšçäž¡èŠªåªæ§ãªã¬ã³ãã³ãŒãã£ã³ã°éå±ããç²åã§ããããã®2ã€ã®ã¢ãããŒãã¯ãããããã¢ãžã¥ãã³ãååç©ããªã³ãçµç¹ã«ãå ç«èª¿ç¯ç©è³ªãæææã®å ç«çްèã«ã¿ãŒã²ãã£ã³ã°ããã®ã«æé©ãªæ¹æ³ã§ããã
è»äººã®å®éšçšã¯ã¯ãã³ã®æžå¿µã«å ããæ°é人ããããã¯ãããžãŒã«ããã¯ã¯ãã³ã®çŸ©åä»ãã«è¿œéããå¯èœæ§ãé«ããå人ã®äœçœ®æ å ±ãšå人ã®ä»£è¬ããŒã¿ã远跡ããããšã¯ãæ¿åºãä¿å¥çã«ãšã£ãŠããŸãã«ã倧ããªåã§ãããããã«èšãã°ããããã®æè¡ãå人ããæ¿åºã«çååŠã·ã°ãã«ãéãããšãã§ãããªãããããããã®æè¡ã¯æ¿åºããå人ã«çååŠãå€ããã·ã°ãã«ãéãèœåãæã£ãŠããã®ã ãããæ¿åºãé éæäœã§äººã®æèãææ ãçåœæ©èœã«åœ±é¿ãäžãããã³ã³ãããŒã«ãããããèœåã®éçãšå®å šçã¯äœã ãããïŒãããã¯ãããžãŒã¯ããŒã¿ã«åºã¥ãå šèœæãæ¯é è ã«äžããå ¬è¡è¡çãè£ ã£ãæå§çãªçµ±æ²»äžçãäœãäžããå¯èœæ§ãããã
"ããªãã«ã§ããããšÂ "ãšã¯ïŒ
ãããŒãã»Fã»ã±ããã£ã»ãžã¥ãã¢ãå«ã40人ã®è¬æŒè ã«ãã10æ16ïœ18æ¥ã®ã21äžçŽã«ãããå¥åº·ãšèªåŸæ§ã®ä¿è·ããªã³ã©ã€ã³äŒè°ã«ç»é²ããèªåã®å¥åº·ã®æè·è ãšãªãåãã€ãããã
"ãããŒãã»Fã»ã±ããã£ã»ãžã¥ãã¢Â "ãšÂ "Children's Health Defense "ããã®ç¡æãã¥ãŒã¹ãææ°æ å ±ãåãåãããã«ç»é²ãããCHDã¯ãåã©ããã¡ã®å¥åº·ãå®ãããã§ã«å·ã€ãã人ãã¡ã®ããã«æ£çŸ©ãåã¡åãããã«ãæ³çãªãã®ãå«ããå€ãã®æŠç¥ãèšç»ããŠããŸããCHDã®ããã·ã§ã³ãæåãããããã«ã¯ãçæ§ã®ãæ¯æŽãäžå¯æ¬ ã§ãããšãã³ã°ã¯æžããŠããŸãã
åèåç»
è³IT ãã¬ã€ã³ãã㯠ãã¬ã€ã³ãã·ã³ã€ã³ã¿ãŒãã§ã€ã¹BMI ãNHKãã€ãšãã¬è¶ å®çŸ©ã
åèèšäº
1.  ãã®ãããã¯ãModerna瀟ãšç±³åœæ¿åºãå
±åéçºããã人éã®DNAãå€åãããå®éšçãªæ°ã¯ã¯ãã³ãé
åããããšãã§ããã
2.  ãããã¥ãŒã¶ã¯ãåœé²é«çç ç©¶èšç»å±ïŒDARPAïŒããã³éžè»ç ç©¶å±ãã750äžãã«ã®å©æéãç²åŸããŸããããã®å©æéã¯ãè€æ°ã®äœå ååŠç©è³ªãé£ç¶çã«ç£èŠã§ããåã蟌ã¿åãã€ãªã»ã³ãµãŒã®éçºã«å ãŠãããäºå®ã§ãã
3. ðºðžéžè»ææçç ç©¶æïŒãã©ãŒããããªãã¯ïŒ
4  ðºðžåœé²é«çç ç©¶èšç»å±DARPA
5  N3ããã°ã©ã ã§ã¯ãå¥åžžè
ã®ããã®é«æ§èœãªåæ¹åãã¬ã€ã³ã»ãã·ã³ã»ã€ã³ã¿ãŒãã§ãŒã¹ã®éçºãç®æããŠããŸãã
6.  ã¢ã¡ãªã«æ¿åºã®åœé²é«çç ç©¶èšç»å±ïŒDARPAïŒã¯ãå人ã®ãç¡æèã®è³ä¿¡å·ããåæãããã®äººã®èããææ ã倿ããç ç©¶ããã°ã©ã ãéå§ããã
7.  ããã®ç¥çµç§åŠãšç¥çµæè¡ã®æ¥éãªé²æ©ã¯ãããã®è³ããã®æ
å ±ãžã®ã¢ã¯ã»ã¹ãåéãå
±æãæäœã®åäŸã®ãªãå¯èœæ§ãéããã®ã§ããã
ãã®ãããªå¿çšã¯ãäºæãã¬çµæãé²ãããã«å¯ŸåŠãã¹ãã人暩ååã«å¯ŸããéèŠãªèª²é¡ãæèµ·ããã
8.  ãã®æ³åŸãçãŸããçç±ã¯ãããããè¿ããã¡ã«ä»ã®åœã§ãåãããã«å¶å®ããããšæããŸããããã§ã«ããªãã®æ°ã®äººã
ãããã¯ã人éã§ã¯ãªãããã©ã³ã¹ãžã§ããã¯ãªååšã«ãªã£ãŠããããã§ãã
COVIDã¯ã¯ãã³ãå€ç°åæ§ãæã¡ãããã®DNAãå€åãããããšã¯åšç¥ã®äºå®ã§ãã
9 è³ç§åŠãšçç©åŠã®é²æ©ã§ããã«ãã«ã¢ããã«ãšãªã£ã人éããã¯ãçç©ãšã¯ã¢ã«ãŽãªãºã ã§ãããçç©ã®é²åãè¶
ããŠäººéãèªç±ã«çåœããã¶ã€ã³ããæä»£ãããŒã¿ãææãããã®ã¯å
šãŠãææãããäžäœäœè
ããããªãã®ãïŒ
10   "ã¹ã«ã€ãããïŒIBMïŒ "ãã€ã¯ããããã®èºé²ãçºè¡šãAIãµã€ããŒããŒãã§äººé¡ãENSLAVE...äººé¡æ»
亡ãè¿ã¥ãã